Clinical Trials Directory

Trials / Terminated

TerminatedNCT00523367

COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI

COPD Patients Diagnosed With Gastro Esophageal Reflux Disease Have Decreased Rates of COPD Exacerbations After Treatment With High Dose Proton Pump Inhibitor Therapy (Esomeprazole or Lansoprazole)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine which COPD patients have GERD and if COPD patients with GERD treated with high dose lansoprazole for 1 year decreases the frequency of COPD exacerbations compared to the previous year without treatment.

Detailed description

Gastroesophageal reflux disease (GERD) is a common esophageal disorder with 40% of the US adult population experiencing symptoms monthly. Pulmonary diseases associated with GERD may include pneumonia, pulmonary fibrosis, asthma, or chronic bronchitis. The latter may be a manifestation of chronic obstructive pulmonary disease (COPD), suggesting GERD as a risk factor for acute exacerbation of COPD. Acute exacerbations of COPD are a major cause of morbidity and mortality in patients with the disease. Recent work suggests that COPD patients with a minimum of weekly reflux symptoms have an increased number of COPD exacerbations that those who are either asymptomatic or have GERD symptoms less than once a week. On this basis, we theorized that in patients with COPD, who also have gastro esophageal reflux disease are at increase risk for acute exacerbations of COPD. To test this question, we will determine which COPD patients have GERD by 24 hour pH testing, treat their GERD with esomeprazole or lansoprazole for 1 year, and compare the number of COPD exacerbations during the treatment period to the previous year.

Conditions

Interventions

TypeNameDescription
PROCEDURE24 hour pH testing24 hour pH testing will be used to screen patients

Timeline

Start date
2007-08-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2007-08-31
Last updated
2013-01-18
Results posted
2012-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00523367. Inclusion in this directory is not an endorsement.

COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI (NCT00523367) · Clinical Trials Directory